R

Redbiotec AG

11 employees

Pioneer in therapeutic bacteria for treating cancer and genetic disorders

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Protein complexes
Immuno-oncology
Gene therapy delivery
Vaccines
Pancreatic cancer
Cervical cancer
Biologics
Oncolytic bacteria
Protein engineering
HPV
Herpes
Immunotherapy
Therapeutics
Proteins
Microbial engineering
Oncolytic virus
Virus-like particles (VLPs)
Therapeutic vaccine
HSV-2

Date founded

2006

Funding rounds raised

R

Redbiotec AG raised undisclosed on November 27, 2014

Investors: Redalpine

FAQ